Local delivery of resveratrol using polycaprolactone nanofibers for treatment of periodontal disease

Journal of Drug Delivery Science and Technology

Volumn 30, Issue , 2015, Pages 408-416

  Zupančič, Špela ^a   Baumgartner, Saša ^a   Lavrič, Zoran ^a   Petelin, Milan ^a   Kristl, Julijana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Controlled release; Drug loading; Electrospinning; Nanofiber; Periodontal diseases; Polycaprolactone

Indexed keywords

NANOCRYSTAL; NANOFIBER; ORGANIC SOLVENT; POLYCAPROLACTONE; RESVERATROL;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ELECTROSPINNING; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MORPHOLOGY; PERIODONTAL DISEASE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

EID: 84949544937     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.07.009     Document Type: Article

References (39)

1. A.B. Berezow, and R.P. Darveau Microbial shift and periodontitis Periodontol. 2000 55 2011 36 47
2. A. Akcali, O. Huck, H. Tenenbaum, J.L. Davideau, and N. Buduneli Periodontal diseases and stress: a brief review J. Oral Rehabil. 40 2013 60 68
3. R.J. Genco, and W.S. Borgnakke Risk factors for periodontal disease Periodontol. 2000 62 2013 59 94
4. P. Bullon, H.N. Newman, and M. Battino Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction? Periodontol. 2000 64 2014 139 153
5. D. Miricescu, A. Totan, B. Calenic, B. Mocanu, A. Didilescu, M. Mohora, T. Spinu, and M. Greabu Salivary biomarkers: relationship between oxidative stress and alveolar bone loss in chronic periodontitis Acta Odontol. Scand. 72 2014 42 47
6. E. Baltacioglu, P. Yuva, G. Aydin, A. Alver, C. Kahraman, E. Karabulut, and F.A. Akalin Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease? J. Periodontol. 85 2014 1432 1441
7. Z. Pavlica, M. Petelin, A. Nemec, D. Erzen, and U. Skaleric Measurement of total antioxidant capacity in gingival crevicular fluid and serum in dogs with periodontal disease Am. J. Vet. Res. 65 2004 1584 1588
8. Š. Zupančič, P. Kocbek, S. Baumgartner, and J. Kristl Nanodelivery systems for treatment of periodontal disease Curr. Pharm. Des. 21 2015 3257 3271
9. W. Teughels, M. Van Essche, I. Sliepen, and M. Quirynen Probiotics and oral healthcare Periodontol. 2000 48 2008 111 147
10. M. Gulati, V. Anand, V. Govila, and N. Jain Host modulation therapy: an indispensable part of perioceutics J. Indian Soc. Periodontol. 18 2014 282 288
11. P.M. Preshaw, A.F. Hefti, S. Jepsen, D. Etienne, C. Walker, and M.H. Bradshaw Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis J. Clin. Periodontol. 31 2004 697 707
12. A. Rizzo, N. Bevilacqua, L. Guida, M. Annunziata, C. Romano Carratelli, and R. Paolillo Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells Cytokine 60 2012 197 204
13. M.J. Nunez, S. Novio, J. Balboa, J. Seoane, J.A. Suarez, and M. Freire-Garabal Effects of resveratrol on expression of vascular endothelial growth factor in human gingival fibroblasts stimulated by periodontal pathogens Acta Odontol. Scand. 68 2010 239 247
14. J.B. Fordham, A.R. Naqvi, and S. Nares Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol Mediat. Inflamm. 2014 2014 938712
15. S.U. Singh, R.F. Casper, P.C. Fritz, B. Sukhu, B. Ganss, B. Girard Jr., J.F. Savouret, and H.C. Tenenbaum Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol J. Endocrinol. 167 2000 183 195
16. M.Z. Casati, C. Algayer, G. Cardoso da Cruz, F.V. Ribeiro, R.C. Casarin, S.P. Pimentel, and F.R. Cirano Resveratrol decreases periodontal breakdown and modulates local levels of cytokines during periodontitis in rats J. Periodontol. 84 2013 e58 64
17. A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control Release 158 2012 182 193
18. N. Jain, G.K. Jain, S. Javed, Z. Iqbal, S. Talegaonkar, F.J. Ahmad, and R.K. Khar Recent approaches for the treatment of periodontitis Drug Discov. Today 13 2008 932 943
19. M. Petelin, Z. Pavlica, S. Bizimoska, and M. Sentjurc In vivo study of different ointments for drug delivery into oral mucosa by EPR oximetry Int. J. Pharm. 270 2004 83 91
20. M. Zamani, M. Morshed, J. Varshosaz, and M. Jannesari Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases Eur. J. Pharm. Biopharm. 75 2010 179 185
21. T.J. Sill, and H.A. von Recum Electrospinning: applications in drug delivery and tissue engineering Biomaterials 29 2008 1989 2006
22. J. Pelipenko, P. Kocbek, and J. Kristl Critical attributes of nanofibers: preparation, drug loading, and tissue regeneration Int. J. Pharm. 484 2015 57 74
23. T. Potrč, S. Baumgartner, R. Roškar, O. Planinšek, Z. Lavrič, J. Kristl, and P. Kocbek Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs Eur. J. Pharm. Sci. 75 2015 101 113
24. Š. Zupančič, Z. Lavrič, and J. Kristl Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature Eur. J. Pharm. Biopharm. 93 2015 196 204
25. R. Rošic, J. Pelipenko, J. Kristl, P. Kocbek, M. Bešter-Rogač, and S. Baumgartner Physical characteristics of poly (vinyl alcohol) solutions in relation to electrospun nanofiber formation Eur. Polym. J. 49 2013 290 298
26. D.H. Reneker, and A.L. Yarin Electrospinning jets and polymer nanofibers Polymer 49 2008 2387 2425
27. W.K. Son, J.H. Youk, T.S. Lee, and W.H. Park The effects of solution properties and polyelectrolyte on electrospinning of ultrafine poly(ethylene oxide) fibers Polymer 45 2004 2959 2966
28. W.J. Li, K.G. Danielson, P.G. Alexander, and R.S. Tuan Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds J. Biomed. Mater Res. A 67 2003 1105 1114
29. C. Chemical, Product information trans-Resveratrol (CAS 510-36-0), in.
30. L.A. Wegiel, L.J. Mauer, K.J. Edgar, and L.S. Taylor Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers J. Pharm. Sci. 102 2013 171 184
31. S. Kobierski, K. Ofori-Kwakye, R.H. Muller, and C.M. Keck Resveratrol nanosuspensions for dermal application-production, characterization, and physical stability Pharmazie 64 2009 741 747
32. M.A. Woodruff, and D.W. Hutmacher The return of a forgotten polymer - Polycaprolactone in the 21st century Prog. Polym. Sci. 35 2010 1217 1256
33. J. Sun, and S.L. Simon The melting behavior of aluminum nanoparticles Thermochim. Acta 463 2007 32 40
34. T. Matsumoto, and G. Zografi Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization Pharm. Res. 16 1999 1722 1728
35. S.L. Shamblin, L.S. Taylor, and G. Zografi Mixing behavior of colyophilized binary systems J. Pharm. Sci. 87 1998 694 701
36. F.M. Eggert, L. Drewell, J.A. Bigelow, J.E. Speck, and M. Goldner The pH of gingival crevices and periodontal pockets in children, teenagers and adults Arch. Oral Biol. 36 1991 233 238
37. R. Srikar, A.L. Yarin, C.M. Megaridis, A.V. Bazilevsky, and E. Kelley Desorption-limited mechanism of release from polymer nanofibers Langmuir 24 2008 965 974
38. J.M. Goodson Gingival crevice fluid flow Periodontol. 2000 31 2003 43 54
39. C.J. Luo, E. Stride, and M. Edirisinghe Mapping the influence of solubility and dielectric constant on electrospinning polycaprolactone solutions Macromolecules 45 2012 4669 4680